Voriconazole treatment

Disseminated mucormycosis leading to a fatal gastrointestinal perforation in a pediatric case of EBV-associated Hemophagocytic lymphohistiocytosis

mycolabadmin

A 12-month-old girl with a severe immune system disorder (HLH) triggered by Epstein-Barr virus developed a life-threatening fungal infection (mucormycosis) that spread throughout her digestive system. Despite aggressive treatment with multiple antifungal medications and emergency surgery, the infection caused her intestines to perforate, leading to her death. The case highlights the difficulty in recognizing fungal infections early in immunocompromised children and the need for heightened clinical awareness.

Clinical characterization of immunocompetent patients with Scedosporium detected in respiratory samples: A case series

mycolabadmin

This study examined eight elderly patients without compromised immune systems who had the fungus Scedosporium detected in their lungs. All patients had a condition called bronchiectasis, and most had previously suffered from MAC disease. The researchers found that in most cases, the fungus was just colonizing the lungs without causing active infection. The challenge for doctors is determining whether Scedosporium is simply living in the lungs or actively causing disease.

Knowledge framework and emerging trends of invasive pulmonary fungal infection: A bibliometric analysis (2003–2023)

mycolabadmin

This study examined 20 years of scientific research on invasive lung fungal infections using bibliometric analysis. The research found that the United States leads in fungal infection research, with emerging focus areas including COVID-19-associated fungal infections and new diagnostic methods like metagenomic sequencing. The findings show that diagnosis remains challenging and requires improved detection methods, while treatment typically involves antifungal medications like voriconazole and amphotericin-B.

Sarocladium implicatum: an unusual agent of opportunistic infection in a COVID-19 patient

mycolabadmin

A 64-year-old man hospitalized with COVID-19 developed a serious fungal infection from Sarocladium implicatum, an unusual fungus rarely found in humans. The infection appeared in his bloodstream and lungs while his immune system was severely weakened by the virus and medications. Doctors identified the fungus using genetic testing and successfully treated him with voriconazole antifungal medication. This case highlights how COVID-19 patients in intensive care are vulnerable to rare opportunistic infections that require specialized laboratory testing to identify and treat.

Investigating the Increasing Azole Resistance in Candida Infections Among Critically Ill Patients: Experience From a Tertiary-Level Setup in North India

mycolabadmin

This study tracked the increase in drug-resistant yeast infections in hospitalized patients in India from 2023 to 2025. The researchers found that common antifungal medications like fluconazole are becoming less effective, with resistance rates nearly doubling over the study period. The good news is that newer antifungal drugs called echinocandins remained highly effective. The findings highlight the need for better infection control measures and more careful use of antifungal medications.

Life-threatening airway stenosis due to Scedosporium infection during nontuberculous mycobacteria treatment: A case report

mycolabadmin

A 73-year-old woman with arthritis being treated with immunosuppressive drugs developed a severe fungal airway infection caused by a rare fungus called Scedosporium apiospermum. Her airway became dangerously narrowed, requiring emergency support with an artificial lung machine while doctors inserted a stent to open her airway. After correctly identifying the fungus and treating it with an antifungal medication called voriconazole, she recovered well with complete healing of the infection.

Changing Climate, Changing Candida: Environmental and Social Pressures on Invasive Candidiasis and Antifungal Resistance in Latin America

mycolabadmin

Invasive fungal infections caused by Candida species are becoming increasingly common and dangerous in Latin American hospitals, with newer strains showing resistance to multiple antifungal drugs. Rising temperatures from climate change and widespread use of fungicides in agriculture appear to be selecting for these resistant fungi. Most hospitals in the region lack advanced diagnostic tools to quickly identify which fungal strain is causing infection, leading to delayed and sometimes inappropriate treatment. Implementing better diagnostic access, stricter antifungal use policies, and coordinated surveillance programs across the region could help control this growing public health problem.

Invasive Saprochaete capitata Infection in an Immunocompromised Patient With Acute Myeloid Leukemia: A Case Report

mycolabadmin

A 46-year-old man with blood cancer developed a serious fungal infection caused by Saprochaete capitata during chemotherapy. This rare but dangerous fungus was found in his blood and lungs, causing fever and breathing problems. The patient was successfully treated with a combination of two antifungal medications and fully recovered, though this infection typically has a high death rate.

Phaeohyphomycosis due to Nigrograna chromolaenae in a cardiac transplant patient

mycolabadmin

A 71-year-old heart transplant patient developed a slowly growing bump on his finger caused by a rare fungus called Nigrograna chromolaenae. Doctors initially tried common antifungal medications that didn’t work well, but the patient improved significantly when switched to posaconazole treatment. This is the first documented case of this particular fungus infecting a human, highlighting the importance of accurately identifying fungi to choose the right treatment.

Life-threatening airway stenosis due to Scedosporium infection during nontuberculous mycobacteria treatment: A case report

mycolabadmin

A 73-year-old woman with arthritis treated with immunosuppressive drugs and a lung infection developed a life-threatening narrowing of her airway caused by a rare fungal infection called Scedosporium apiospermum. Doctors used a combination of emergency measures including a breathing support machine, insertion of a special tube to keep the airway open, and strong antifungal medication to treat the infection. After six months of treatment, the fungal infection was completely gone and the special airway tube was successfully removed, allowing normal healing.

therapeutic action: Voriconazole treatment